Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 As leukemia options grow, drugs jockey to be first-line therapies.

× No keyword cloud information.

3 in total

1. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.

Authors: Jorge E Cortes; Dong-Wook Kim; Hagop M Kantarjian; Tim H Brümmendorf; Irina Dyagil; Laimonas Griskevicius; Hemant Malhotra; Christine Powell; Karïn Gogat; Athena M Countouriotis; Carlo Gambacorti-Passerini
Journal: J Clin Oncol Date: 2012-09-04 Impact factor: 44.544

2. Ponatinib in refractory Philadelphia chromosome-positive leukemias.

Authors: Jorge E Cortes; Hagop Kantarjian; Neil P Shah; Dale Bixby; Michael J Mauro; Ian Flinn; Thomas O'Hare; Simin Hu; Narayana I Narasimhan; Victor M Rivera; Tim Clackson; Christopher D Turner; Frank G Haluska; Brian J Druker; Michael W N Deininger; Moshe Talpaz
Journal: N Engl J Med Date: 2012-11-29 Impact factor: 91.245

3. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Authors: Giuseppe Saglio; Dong-Wook Kim; Surapol Issaragrisil; Philipp le Coutre; Gabriel Etienne; Clarisse Lobo; Ricardo Pasquini; Richard E Clark; Andreas Hochhaus; Timothy P Hughes; Neil Gallagher; Albert Hoenekopp; Mei Dong; Ariful Haque; Richard A Larson; Hagop M Kantarjian
Journal: N Engl J Med Date: 2010-06-05 Impact factor: 91.245

3 in total

1 in total

1. Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era.

Authors: Zafar Iqbal; Aamer Aleem; Mudassar Iqbal; Mubashar Iqbal Naqvi; Ammara Gill; Abid Sohail Taj; Abdul Qayyum; Najeeb ur-Rehman; Ahmad Mukhtar Khalid; Ijaz Hussain Shah; Muhammad Khalid; Riazul Haq; Mahwish Khan; Shahid Mahmood Baig; Abid Jamil; Muhammad Naeem Abbas; Muhammad Absar; Amer Mahmood; Mahmood Rasool; Tanveer Akhtar
Journal: PLoS One Date: 2013-02-08 Impact factor: 3.240

1 in total